Medical Science Monitor · 2019 · 43 citations · 21 references
Veterinary MedicinePharmacologyToxicologyImmunopathologyInflammationInnate ImmunityAcute InflammationAcute Lung InjuryInflammatory Cell ResponsesInflammatory SignalingMechanisms Of Toxic InjuryPulmonary InflammationAcute Inflammatory ResponseAcute Lung Injury PathophysiologyCellular Inflammatory ResponsesInflammatory Stress ResponsesMechanisms Of Lung ToxicityNrf2 Pathway ActivationOxidative Stress InjuryPulmonary Oxidative Stress
BACKGROUND Mesenchymal stem cells (MSCs) show anti-oxidative and anti-inflammatory effects that have prompted further research into their potential applications in treating paraquat (PQ) poisoning cases in emergency rooms. We assessed the protective effects, underlying mechanisms, and secondary inflammatory responses of MSCs on PQ-induced acute lung injury. MATERIAL AND METHODS Sprague-Dawley rats were injected intraperitoneally with PQ (20 µg per gram of body weight). MSCs were injected through the caudal vein 1 h after PQ treatment. The severity of lung injury and oxidative stress and levels of inflammatory mediators were examined with and without MSC grafting. Expression levels of TLR4, NF-kappaB, p65, Nrf2, HO-1, and activated caspase-3 protein were determined by Western blotting. RESULTS Administration of MSCs significantly decreased the levels of TNF-alpha, IL-1ß, and IL-6 and polymorphonuclear neutrophil (PMN) count in the bronchoalveolar lavage fluid (BALF) of rats with PQ-induced ALI. In addition, MSC also effectively reduced the wet-to-dry lung weight ratio, lung injury score, and the levels of MDA and 8-OHdG. Conversely, MSC increased SOD and GSH-PX activity in the lung tissue. Moreover, MSC significantly upregulated HO-1, Nrf-2 protein expression in the lung tissue. In contrast, the levels of TLR4, NF-kappaB p65 and activated caspase-3 protein were decreased in MSC-treated rats (P<0.05). CONCLUSIONS Treatment with MSCs overexpressed Nrf2 gene and activated downstream antioxidant HO-1, leading to inhibit oxidative stress, cell apoptosis and inflammatory response in lung tissue, thereby significantly improving PQ-induced acute lung injury in rats.
21
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold, Ludwig Kappos, Douglas L. Arnold et al. · New England Journal of Medicine · 2012 · 1.7K citations · Full text
Medicine, Neurology, Pharmacotherapy +17
Luis A. Ortiz, Frederica Gambelli, C.E. McBride et al. · Proceedings of the National Academy of Sciences · 2003 · 1.5K citations · Full text
Suellen Iara Guirra Rosa, Fabrício Rios-Santos, Sikiru Olaitan Balogun et al. · Phytomedicine · 2015 · 143 citations
Life Sciences, Immunology, Pathology +17